Dr. Omid Rowshan, MD

Dr. Rowshan practices at Virtua Willingboro Hospital in Willingboro, New Jersey, part of Virtua Health.

Dr. Rowshan's NPI, 1285680371, was assigned on May 26, 2006. Dr. Rowshan holds New Jersey license 25MA07055100.

Dr. Rowshan's primary practice is Virtua Willingboro Hospital, at 218A Sunset Road, Willingboro, NJ 08046 in Burlington County. The practice phone is (609) 835-2900. Dr. Rowshan also practices at Virtua Willingboro Hospital, 218 Sunset Rd, Willingboro, NJ 08046.

Dr. Rowshan's primary practice is Virtua Willingboro Hospital in Willingboro, New Jersey, part of Virtua Health. Dr. Rowshan is also affiliated with Cooper University Hospital. The medical group on file is Virtua Health. Dmand AI also links Dr. Rowshan to 7 more medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rowshan practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Rowshan's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Rowshan's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 651 Medicare services from Dr. Rowshan across 4 procedure codes in 2024, for 565 Medicare patients. Medicare paid $78,859 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 565 Medicare patients who saw Dr. Rowshan in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rowshan's median patient age at 45, with 56% women.

In 2024, Dr. Rowshan wrote 465 Medicare Part D claims for 295 patients. 97% of them were for generic drugs. CMS names the drug for 320 of them, across 13 drugs with 11 or more claims each, at $1,047 in total drug cost. In 2023, CMS named 380 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 70 out of 100 for Dr. Rowshan for performance year 2024, reported individually. Dr. Rowshan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 11 general payments to Dr. Rowshan from 5 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 85% of the total. Davol Inc. paid the most, $750.